WH Pharm Flashcards

1
Q

In 2015, FDA replaced the ____ system of defining pregnancy risk with _____ _______ _______

A

category (A/B/C/D/X)

narrative risk summary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

define teratogen

A

a term used to denote the result of a hazard assessment on a particular agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

teratogenic effect depends on six factors…can you name them?

A
physical/chem nature of drug
dose
duration
frequency
route of exposure
gestational timing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does ‘teratogen’ REALLY mean?

A

POTENTIAL
teratogenic potential

(it indicates a drug MAY have potential for producing developmental toxicity given appropriate conditions, as was observed with Thalidomide)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the baseline risk for congenital defects?

A

baseline risk due to any cause 3-4% (1 in 28 babies)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The extent to which drug will affect development of fetus depends on

A

Properties of drug,
dose,
route,
duration

Timing of exposure

Genetic composition and biologic susceptibility of mother and fetus (think about ETOH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Name two high risk teratogen drugs

A

thalidomide

isotretinoin (Vit A derivative)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is required of the female patient in order to be prescribed Isotretinoin?

A

She must agree to be on contraception

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What percentage of exposed pregnancies have adverse events due to HIGH RISK teratogenic drugs?

A

25%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Name two moderate risk teratogenic drugs

A

carbamazepine

valproic acid

(often anti-epileptic drugs are moderate risk)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the risk of adverse event for moderate risk teratogen drugs?

A

“5 to 20-fold increase rate”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What must ALWAYS be addressed when considering pharmacological needs of female patients?

A

potential for conception

“We are ALWAYS in preconception planning”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

In weeks 1 & 2 gestation, during blastogenesis, what is likely result of teratogen?

A

embryo is destroyed, pregnancy is terminated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

In Days 18-60 gestation, during organogenesis, what is likely result of teratogen?

A

organ system abnormalities (heart or neural tube defects)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

> 60 days of growth and maturation of gestation, what is likely result of teratogen?

A

CNS abnormalities

“For remainder of pregnancy, exposure to teratogens may result in growth retardation, CNS abnormalities or, in extreme cases, death.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

According to the Briggs “Bible” of drugs in pregnancy, what is the final word on quinolones?

A

use with caution, and only if no other option is available

“Briggs: Most would still say due to these concerns and animal data, quinolones should be used cautiously during pregnancy, especially during the first trimester.”

17
Q

At what age should all women get osteoporosis screening? men?

A

all women >65 y/o
men >70 y/o

***** also ~
women 50-64 with risk factors
pts on steroids or anti-estrogen/anti-testosterone treatment

18
Q

what is the primary screening tool for osteoporosis?

A

dexa scan

19
Q

suspect osteoporosis in adults >50 yrs old with BMD T-score ______ at ______

A

-2.5

at femoral neck, total hip, or lumbar spine

20
Q

list four pharmacologic agents used for treatment of osteoporosis

A

bisphosphonates (alendronate (Fosamax))
denosumab (Prolia)
raloxifene (Evista)
PTH and related peptide analogs

(Calcium and Vit D, supplement these if needed)

21
Q

what type of osteoporosis pt cannot use bisphosphonates?

A

those with low eGFR

use denosumab (Prolia)

22
Q

what type of osteoporosis pt should avoid Teriparatide?

A

those with elevated PTH

23
Q

normal DEXA scan range - standard deviation from young healthy is the T-score _____________

A

+/- 1 from 0

24
Q

OSTEOPENIA DEXA scan range - standard deviation from young healthy is the T-score _____________

A

1.0 - 2.5 standard deviations below 0

25
Q

OSTEOPOROSIS DEXA scan range - standard deviation from young healthy is the T-score _____________

A

2.5 or more below 0

26
Q

name four antiresorptive medications for the OP treatment of osteoporosis

A

bisphosphonates
denosumab
SERMs (tamoxifen, raloxifene)
estrogen

27
Q

name a SERM that is good for osteoporosis vertebral fracture

A

Raloxifene

28
Q

name an anabolic osteoporosis medication used to stimulate bone formation

A

teriparatide (Forteo) -

  • it stimulates osteoblasts
29
Q

When it comes to bone strength/osteoporosis ~

Estrogen compounds are believed to have an osteoblast-_______ effect.
stimulating, inhibiting

A

stimulating.

Estrogen compounds are believed to have an osteoblast-stimulating effect.

When the amt of estrogen in blood falls to very low levels after menopause, the balance b/w bone-building of osteoblasts and bone-degrading activity of osteoclasts tips toward bone degradation.

30
Q

three drug classifications that affect the autonomic nervous system and affect uterine contractility (which is clinically most important in third trimester of pregnancy)

A
  • muscarinic agonists
    - they stimulate contraction
  • alpha agonists
    - they also stimulate contraction
  • beta 2
    - they cause relaxation of the uterus
31
Q

what effect do calcium channel blockers have on uterine contractibility

A

uterine muscle relaxation (special caution for late trimester, near delivery time)

32
Q

after L&D, what three medication neonatal effects are commonly observed?

A

kernicterus
(can be observed with TMP/SMX and phenytoin)

resp depression
(often seen with benzos, opioids)

withdrawal
(ilicit drugs, antidepressants)

33
Q

prescribing and pregnancy -

what should be done for pts who may become pregnant?

A

pts should be screened for problematic prescriptions and OTC medications
make changes in advance of pregnancy, plan for accidental pregnancy

34
Q

how much alcohol is safe during pregnancy?

A

none.

no safe time
no safe amount

35
Q

What changes in pregnancy affect drug clearance?

A

cardiac output and volume of distribution

36
Q

In terms of medical management of pregnant patient, what is the most common consequence of changes in maternal physiology?

A

a decrease in total serum drug concentrations, due to increased Volume of Distribution (Vd)

37
Q

how to dose meds for pregnant patients:

A

start at lower end of usual adult dose range, titrate up based on monitoring (often ends up at the higher end of dose range)

38
Q

treatments for pregnant pts for

nausea/vomiting

A

first - nonpharm like spacing meals, avoiding triggers, ginger

second - vitamins, antihistamines

third - dopamine antagonist (metoclopramide)

fourth - serotonin antagonist (ondansetron) or corticosteroids (methylprednisolone, dexamethasone, prednisolone)